KR930700098A - Veterinary Treatment - Google Patents

Veterinary Treatment

Info

Publication number
KR930700098A
KR930700098A KR1019920702371A KR920702371A KR930700098A KR 930700098 A KR930700098 A KR 930700098A KR 1019920702371 A KR1019920702371 A KR 1019920702371A KR 920702371 A KR920702371 A KR 920702371A KR 930700098 A KR930700098 A KR 930700098A
Authority
KR
South Korea
Prior art keywords
veterinary acceptable
amoxycillin
acceptable derivative
acid
sheep
Prior art date
Application number
KR1019920702371A
Other languages
Korean (ko)
Other versions
KR100190869B1 (en
Inventor
차알즈 크래크넬 빅터
Original Assignee
원본미기재
비이참 그루우프 피이엘시이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 비이참 그루우프 피이엘시이 filed Critical 원본미기재
Publication of KR930700098A publication Critical patent/KR930700098A/en
Application granted granted Critical
Publication of KR100190869B1 publication Critical patent/KR100190869B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Soil Working Implements (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A formulation comprising amoxycillin or a veterinarily acceptable derivative thereof, clavulanic acid or a veterinarily acceptable derivative thereof, and a veterinarily acceptable carrier is used in the treatment of pneumonic pasteurellosis in lambs or sheep.

Description

수의학적 치료Veterinary Treatment

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (7)

어린 양 또는 양에 있어서 폐렴성 파스퇴렐라균 감염증의 치료에 사용하는 약제의 제조에서, 효과적 양의 암옥시실린 또는 그의 수의학적으로 허용가능한 유도체, 클라부산 산 또는 그의 수의학적으로 허용가능한 유도체 및 수의학적으로 허용가능한 부형액으로 구성되는 배합물의 사용.In the manufacture of a medicament for use in the treatment of pneumococcal Pasteurella infection in a lamb or sheep, an effective amount of amoxycillin or a veterinary acceptable derivative thereof, clavous acid or a veterinary acceptable derivative thereof and Use of formulations consisting of veterinary acceptable excipients. 효과적 양의 암옥시실린 또는 그의 수의학적으로 허용가능한 유도체, 클라부란 산 또는 그의 수의학적으로 허용가능한 유도체, 및 수의학적으로 허용가능한 부형액을 어린양 또는 양에 투여하는 것으로 구성되는, 어린양 또는 양에 있어서 폐렴성 파스퇴렐라균감염증의 치료방법.A lamb, comprising an effective amount of amoxycillin or a veterinary acceptable derivative thereof, claburan acid or a veterinary acceptable derivative thereof, and a veterinary acceptable excipient in the lamb or sheep A method of treating pneumococcal Pasteurella infection in sheep. 효과적 양의 암옥시실린 또는 그이 수의학적으로 허용가능한 유도체, 클라부란 산 또는 그의 수의학적으로 허용가능한 유도체 및 수의학적으로 허용가능한 부형액으로 구성되는 어린양 또는 양에 있어서 폐렴성 파스퇴렐라균감염증을 치료하는 조성물.Pneumococcal Pasteurella infection in a lamb or sheep consisting of an effective amount of amoxycillin or a veterinary acceptable derivative thereof, claburan acid or a veterinary acceptable derivative thereof and a veterinary acceptable excipient Composition to treat. 제1항에 있어서, 암옥시실린이 트리히드레이트 또는 나트륨 염으로서 사용되는 사용.The use according to claim 1, wherein amoxycillin is used as trihydrate or sodium salt. 제1 또는 4항에 있어서, 클라부란산이 칼륨 염으로서 사용되는 사용.The use according to claim 1 or 4, wherein claburanic acid is used as the potassium salt. 제1, 4 또는 5항에 있어서, 부형액이 주사에 적합한 오일인 사용.Use according to claim 1, 4 or 5, wherein the excipient is an oil suitable for injection. 제1, 4, 5 또는 6항에 있어서, 암옥시실린 또는 그의 유도체 및 클라부란 산 또는 그의 유도체가 6:1-1:1의 중량비로 존재하는 사용.Use according to claim 1, 4, 5 or 6, wherein amoxycillin or derivatives thereof and clavulanic acid or derivatives thereof are present in a weight ratio of 6: 1-1: 1. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019920702371A 1990-03-30 1992-09-29 Veterinary treatment KR100190869B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9007143.2 1990-03-30
GB909007143A GB9007143D0 (en) 1990-03-30 1990-03-30 Veterinary composition
PCT/GB1991/000442 WO1991015208A1 (en) 1990-03-30 1991-03-25 Veterinary treatment

Publications (2)

Publication Number Publication Date
KR930700098A true KR930700098A (en) 1993-03-13
KR100190869B1 KR100190869B1 (en) 1999-06-01

Family

ID=10673543

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920702371A KR100190869B1 (en) 1990-03-30 1992-09-29 Veterinary treatment

Country Status (15)

Country Link
EP (1) EP0521974B1 (en)
JP (1) JP3032904B2 (en)
KR (1) KR100190869B1 (en)
AT (1) ATE135213T1 (en)
AU (1) AU648787B2 (en)
CA (1) CA2079328C (en)
DE (1) DE69117943T2 (en)
DK (1) DK0521974T3 (en)
ES (1) ES2085990T3 (en)
GB (1) GB9007143D0 (en)
GR (1) GR3020197T3 (en)
IE (1) IE71191B1 (en)
NZ (1) NZ237615A (en)
WO (1) WO1991015208A1 (en)
ZA (1) ZA912369B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009446D0 (en) * 1990-04-26 1990-06-20 Beecham Group Plc Veterinary composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT64897B (en) * 1975-04-14 1977-08-18 Beecham Group Ltd Process for the preparation of novel antibacterial agents
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد K-clavulanate/tri hydrate formulations
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
GB9009446D0 (en) * 1990-04-26 1990-06-20 Beecham Group Plc Veterinary composition

Also Published As

Publication number Publication date
ES2085990T3 (en) 1996-06-16
DE69117943T2 (en) 1996-08-01
WO1991015208A1 (en) 1991-10-17
GR3020197T3 (en) 1996-09-30
DK0521974T3 (en) 1996-04-15
JP3032904B2 (en) 2000-04-17
JPH05505818A (en) 1993-08-26
EP0521974B1 (en) 1996-03-13
AU648787B2 (en) 1994-05-05
AU7570891A (en) 1991-10-30
NZ237615A (en) 1992-01-29
CA2079328A1 (en) 1991-10-01
EP0521974A1 (en) 1993-01-13
ZA912369B (en) 1992-02-26
IE911074A1 (en) 1991-10-09
CA2079328C (en) 2002-01-29
GB9007143D0 (en) 1990-05-30
DE69117943D1 (en) 1996-04-18
IE71191B1 (en) 1997-02-12
ATE135213T1 (en) 1996-03-15
KR100190869B1 (en) 1999-06-01

Similar Documents

Publication Publication Date Title
DK77090A (en) Immunomodulatory AZASPIRANS
NO870241L (en) HYPOGLYCHEMICAL TIAZOLIDE INDIA.
KR920002144A (en) Inflammatory bowel disease prevention and treatment containing zinc L-carnosine salt or its complex as an active ingredient
ES2077199T3 (en) NEW PIPERACINES 1,4-DISSTITUTED, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES2140565T3 (en) NEW DERIVATIVES OF PIRAZINE-CARBOXAMIDE, ITS PREPARATION AND ITS USE IN MEDICINES.
DE69116380D1 (en) PHARMACEUTICAL PREPARATION FOR TREATING EXTENDED COAGLING TIME
BR9406059A (en) Pharmaceutical composition and method for treating helminth infection in an animal
ES2108129T3 (en) NEW DERIVATIVES OF PIRAZINE, ITS PREPARATION AND USE.
ES2087623T3 (en) DERIVATIVES OF BENCIMIDAZOLE AS AN ANTIMICROBIAL AGENT AGAINST CAMPYLOBACTER PYLON.
DE68916956D1 (en) ACTIVE AGENT: LIPID COMPLEX WITH HIGH RATIO.
KR930700098A (en) Veterinary Treatment
ES2052670T3 (en) USE OF 2-PIRIMIDINYL-1-PIPERAZINE DERIVATIVES.
SE7612962L (en) TIENAMYCIN DERIVATIVES
SE7708176L (en) BENZAMIDE ASSOCIATIONS
KR880004810A (en) Peptic Ulcer Treatment
KR930700100A (en) Veterinary Treatment
KR900017599A (en) Pharmaceutical composition for tumor treatment
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
DE3778858D1 (en) 17-BENZYL SPARTEIN DERIVATIVES CONTAINING POSITIVE INOTROP EFFECTIVE PHARMACEUTICAL PREPARATIONS.
KR890001568A (en) Prevention and treatment of swine dysentery
KR900014372A (en) Thienyl piperazine preparation method and pharmaceutical agent containing same
RU94026368A (en) Substance showing antiadhesion activity with respect to gram-positive microflora
FR2604704B1 (en) 4-PHENYLTHIAZOLE DERIVATIVES, METHOD OF PREPARATION AND THERAPEUTIC USE

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20041230

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee